Literature DB >> 11036027

Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model.

K N Sorensen1, R A Sobel, K V Clemons, L Calderon, K J Howell, P R Irani, D Pappagianis, P L Williams, D A Stevens.   

Abstract

A rabbit model of coccidioidal meningitis was used to compare the therapeutic efficacies of terbinafine (TBF) and fluconazole (FCZ). Hydrocortisone acetate-treated New Zealand White male rabbits were infected intracisternally with either 2.2 x 10(4) or 6.4 x 10(4) Coccidioides immitis arthroconidia. Oral treatment with polyethylene glycol 200 (PEG) twice daily (n = 8), TBF twice daily (n = 9; 200 mg/kg of body weight/day), or FCZ once daily (n = 8; 80 mg/kg/day) began on day 5 and continued for 21 days. Mean survival times were 20, 24, and 32 days for rabbits treated with PEG, TBF, and FCZ, respectively. All of the FCZ-treated animals (100%; P = 0.003), 56% of the TBF-treated animals (P = 0.4), and 25% of the PEG-treated animals survived the length of the study. Both FCZ and TBF were effective at reducing the incidence of paresis. Only FCZ was effective at reducing most neurological and systemic signs. FCZ treatments resulted in lower cerebrospinal fluid (CSF) protein concentrations and leukocyte counts and faster clearing of CSF fungal cultures compared with those for PEG-treated controls, but TBF treatments had no significant effect on these parameters. Neither drug affected CSF glucose levels. Mean serum TBF levels by bioassay were within the range of 3.5 to 6.2 microgram/ml at 1, 2, and 4 h postdosing and 0.35 to 7.0 microgram/ml at 14 h postdosing. No TBF was detected in CSF. Mean FCZ levels (24 to 25.5 h postdosing) by bioassay were 16.4 to 19.2 and 13.5 to 19.2 microgram/ml in serum and CSF, respectively. The reduction in the numbers of CFU in the spinal cord and brain was over 100-fold (P = 0.0005) in FCZ-treated animals and 2-fold (P </= 0.2) in TBF-treated animals compared with those in PEG-treated animals. Histopathologic severity (semiquantitative scoring system) was significantly attenuated by FCZ treatment (P = 0. 05) and was slightly attenuated by TBF treatment compared with that for the controls. In conclusion, TBF appeared to have a slight effect on survival, histology, and reduction of the numbers of CFU in tissue; however, these effects were not significant. FCZ was effective at controlling coccidioidal meningitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036027      PMCID: PMC101607          DOI: 10.1128/AAC.44.11.3087-3091.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography.

Authors:  J H Rex; L H Hanson; M A Amantea; D A Stevens; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Influence of plasma protein binding on the brain uptake of an antifungal agent, terbinafine, in rats.

Authors:  B Machard; P Misslin; M Lemaire
Journal:  J Pharm Pharmacol       Date:  1989-10       Impact factor: 3.765

3.  Bioassay for SF 86-327, a new antifungal agent.

Authors:  V L Kan; D K Henderson; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

Review 4.  Serology of coccidioidomycosis.

Authors:  D Pappagianis; B L Zimmer
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

5.  Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review.

Authors:  P L Williams; R Johnson; D Pappagianis; H Einstein; U Slager; F T Koster; J J Eron; J Morrison; J Aguet; M E River
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

6.  Special features of the clinical use of oral terbinafine in the treatment of fungal diseases.

Authors:  V V Villars; T C Jones
Journal:  Br J Dermatol       Date:  1992-02       Impact factor: 9.302

7.  Antifungal activity of the allylamine derivative terbinafine in vitro.

Authors:  G Petranyi; J G Meingassner; H Mieth
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

8.  Interaction of terbinafine with human serum and serum proteins.

Authors:  N S Ryder; I Frank
Journal:  J Med Vet Mycol       Date:  1992

9.  Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations.

Authors:  J S Hostetler; J Heykants; K V Clemons; R Woestenborghs; L H Hanson; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

10.  Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?

Authors:  D H Dewsnup; J N Galgiani; J R Graybill; M Diaz; A Rendon; G A Cloud; D A Stevens
Journal:  Ann Intern Med       Date:  1996-02-01       Impact factor: 25.391

View more
  6 in total

1.  Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.

Authors:  Emilia Cantón; Javier Pemán; Miguel Gobernado; Angel Viudes; Ana Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Successful use of combination antifungal therapy in the treatment of coccidioides meningitis.

Authors:  Suresh J Antony; Peter Jurczyk; Lisa Brumble
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

3.  Use of terbinafine in mouse and rat models of Pneumocystis carinii pneumonia.

Authors:  Peter D Walzer; Alan Ashbaugh
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.

Authors:  Karl V Clemons; Raymond A Sobel; Paul L Williams; Demosthenes Pappagianis; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits.

Authors:  Karl V Clemons; Javier Capilla; Raymond A Sobel; Marife Martinez; Ann-Jay Tong; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

6.  Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Authors:  K E Zucker; P Kamberi; R A Sobel; G Cloud; D N Meli; K V Clemons; D A Stevens; P L Williams; S L Leib
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.